Thomas S. Marshall

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach

Angelo Antonini, A. Jon Stoessl, Leah Kleinman et al. · Current Medical Research and Opinion · 2018 · 250 citations · Full text

Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial

Michael D. Vardy, H. David Mitcheson, Terri-Ann Samuels et al. · International Journal of Clinical Practice · 2009 · 67 citations

Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder

Sherilyn M. Notte, Thomas S. Marshall, Misun Lee et al. · BMC Urology · 2012 · 51 citations · Full text

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs

Sven Pålhagen, Olof Sydow, Anders Johansson et al. · Parkinsonism & Related Disorders · 2016 · 49 citations · Full text

The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease

Julia Lowin, Kavita Sail, R Baj et al. · Journal of Medical Economics · 2017 · 30 citations · Full text